EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
-13.89%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$4.5B
AUM Growth
-$744M
(-14%)
Cap. Flow
+$122M
Cap. Flow
% of AUM
2.72%
Top 10 Holdings %
Top 10 Hldgs %
18.83%
Holding
979
New
48
Increased
192
Reduced
136
Closed
31
Top Buys
| 1 |
HES
Hess
HES
|
$32.2M |
| 2 |
Netflix
NFLX
|
$31.3M |
| 3 |
Pfizer
PFE
|
$14.6M |
| 4 |
Coca-Cola
KO
|
$12.1M |
| 5 |
East-West Bancorp
EWBC
|
$9.42M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$32.2M |
| 2 |
HMHC
Houghton Mifflin Harcourt Company
HMHC
|
$19.3M |
| 3 |
VMW
VMware, Inc
VMW
|
$15.3M |
| 4 |
Coterra Energy
CTRA
|
$12.9M |
| 5 |
Essential Utilities
WTRG
|
$11.4M |
Sector Composition
| 1 | Technology | 29.9% |
| 2 | Healthcare | 19.98% |
| 3 | Consumer Discretionary | 10.77% |
| 4 | Financials | 9.62% |
| 5 | Industrials | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Goldman Sachs
GS
$223B
| $651K | 0.01% |
2,146
-2,015
| -48% | -$611K |
|
402
MasTec
MTZ
$14B
| $636K | 0.01% |
8,923
+1,456
| +19% | +$104K |
|
403
Phillips 66
PSX
$53.2B
| $634K | 0.01% |
+7,500
| New | +$634K |
|
404
AbCellera Biologics
ABCL
$1.26B
| $627K | 0.01% |
62,000
| – | – |
|
405
Aurinia Pharmaceuticals
AUPH
$1.63B
| $617K | 0.01% |
60,000
| – | – |
|
406
Arch Capital
ACGL
$34.1B
| $616K | 0.01% |
13,800
-4,300
| -24% | -$192K |
|
|
SPWR
407
DELISTED
SunPower Corporation Common Stock
SPWR
| $606K | 0.01% |
40,000
+20,000
| +100% | +$303K |
|
408
CF Industries
CF
$13.7B
| $605K | 0.01% |
7,000
+2,800
| +67% | +$242K |
|
409
Beam Therapeutics
BEAM
$2.11B
| $602K | 0.01% |
14,900
| – | – |
|
410
Citizens Financial Group
CFG
$22.3B
| $590K | 0.01% |
16,333
+2,883
| +21% | +$104K |
|
411
Mondelez International
MDLZ
$79.9B
| $586K | 0.01% |
9,432
-9,419
| -50% | -$585K |
|
412
Laureate Education
LAUR
$4.1B
| $576K | 0.01% |
51,186
+10,000
| +24% | +$113K |
|
413
Pacira BioSciences
PCRX
$1.19B
| $575K | 0.01% |
9,800
| – | – |
|
414
Jones Lang LaSalle
JLL
$14.8B
| $574K | 0.01% |
3,252
+582
| +22% | +$103K |
|
415
Progyny
PGNY
$1.94B
| $574K | 0.01% |
19,328
+500
| +3% | +$14.8K |
|
416
Invesco
IVZ
$9.81B
| $572K | 0.01% |
34,740
+6,035
| +21% | +$99.3K |
|
417
Hartford Financial Services
HIG
$37B
| $558K | 0.01% |
8,600
-1,100
| -11% | -$71.4K |
|
418
Packaging Corp of America
PKG
$19.8B
| $556K | 0.01% |
4,000
+500
| +14% | +$69.5K |
|
|
DCBO
419
Docebo
DCBO
$896M
| $545K | 0.01% |
18,900
| – | – |
|
420
Becton Dickinson
BDX
$55.1B
| $531K | 0.01% |
+2,130
| New | +$531K |
|
421
Legend Biotech
LEGN
$6.66B
| $528K | 0.01% |
9,700
| – | – |
|
|
AMRN
422
Amarin Corp
AMRN
$317M
| $522K | 0.01% |
14,350
| – | – |
|
423
Zai Lab
ZLAB
$3.42B
| $522K | 0.01% |
15,100
| – | – |
|
424
JetBlue
JBLU
$1.85B
| $519K | 0.01% |
57,869
+10,870
| +23% | +$97.4K |
|
425
Brown & Brown
BRO
$31.3B
| $516K | 0.01% |
8,900
| – | – |
|